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Abstract
Introduction: Non-communicable diseases (NCDs) are the leading cause of death and disability worldwide, and
their prevalence in lower- and middle-income countries (LMIC) is on the rise. The burden of chronic health
expenditure born by patient households in these countries may be very high, particularly where out-of-pocket
payments for health care are common. One such country where out-of-pocket payments are especially high is
Ukraine. The financial impact of NCDs on households in this country has not been researched.
Methods: We set out to explore the burden of NCD care in Ukraine with a study of angina patients. Using data
from the Ukraine World Health Survey of 2003 we employed the novel Coarsened Exact Matching approach to
estimate the difference in out-of-pocket payment (OPP) for health care between households with a stable angina
pectoris (a chronic form of IHD) patient and those without. The likelihood of engaging in catastrophic spending
and using various distress financing mechanisms (e.g. sale of assets, borrowing) among angina households
compared with non-angina households was also explored.
Results: Among angina patient households (n = 203), OPP occupied an average of 32% of household effective
income. After matching, angina households experienced significantly higher monthly per capita OPP for health care
(B = $2.84) and medicines (B = $2.94), but were not at significantly higher odds of engaging in catastrophic
spending. Odds of engaging in ‘sale of assets’ (OR = 2.71) and ‘borrowing’ (OR = 1.68) to finance OPP were
significantly higher among angina households.
Conclusions: The cost of chronic care in Ukraine places a burden on individual patient households. Households of
angina patients are more likely to engage in distress financing to cover the cost of treatment, and a high
proportion of patients do not acquire prescribed medicines because they cannot afford them. This warrants further
research on the burden of NCD care in other LMIC, especially where OPP for health care is common. Health policies
aimed at reducing OPP for health care, and especially medicines, would lessen the high health and financial burden
of chronic care. Further research is also needed on the long-term impact of borrowing or sale of assets to finance
OPP on patient households.
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Introduction
The epidemic of non-communicable diseases (NCDs)
that is occurring in lower- and middle- income countries
(LMIC) is well documented [1,2]. In 2008, nearly 80% of
deaths from NCDs occurred in LMIC, caused mostly by
ischemic heart disease (IHD) [3].
What is less understood is how these countries will man-
age the burden of the health costs associated with treating
NCDs, which require different care models to those of
communicable diseases. For example, among patients diag-
nosed with IHD, acute events and hospitalization or death
can be avoided, but only with a daily drug regimen and
long-term medical attention. As a result, management of
IHD and other chronic NCDs may impose a heavy finan-
cial burden on the households of uninsured patients. A re-
cent study showed that more than 50% of IHD patient
households in China, India and Tanzania engaged in cata-
strophic health spending (≥ 40% of non-food expenditures)
due to out-of-pocket payments (OPP) for health care, and
many were turning to distress financing (borrowing, sale of
assets) to cover these costs [4].
The impact of health care costs for NCDs may be es-
pecially important in countries of the former Soviet
Union (fSU), which experience the highest rate of
disability-adjusted life years due to IHD globally, and
where health care systems are struggling to reform
under great economic and human resource constraints.
High OPP for health care in these countries have been
reported [5-9] but there have been no studies of the fi-
nancial burden attributable to IHD specifically. We set
out to explore the impact of IHD in one fSU country,
Ukraine, using a case study of angina patient households.
Ukraine has been relatively ignored in the public health
literature, despite evidence of a high prevalence of NCD
risk factors in the country [10,11] and a health care sys-
tem that has proved unable to meet the needs of its pa-
tients [9,12].
Officially, all Ukrainians are entitled to a guaranteed
package of health care services provided free of charge
at the point of use; however, resource constraints have
led to attempts by the government to limit the range of
services covered in this package. With few exceptions,
outpatient pharmaceuticals have never been covered in
this package. Only 0.5% of Ukraine’s population is cov-
ered by voluntary insurance schemes [13]. In the ab-
sence of pre-payment for care, OPP for drugs and
medicines, service charges, and informal payments to
medical personnel have increased, placing the financial
burden on the shoulders of the patient and their house-
hold [12]. The share of private households’ OPP in total
health expenditure in Ukraine is estimated at about 40.5%,
higher than in neighbouring Belarus (17.4%) and Russia
(28.3%) [14]. A recent analysis of cross-sectional survey
data from Ukraine indicated that 95.5% of respondents
who accessed care in the last four weeks reported making
an OPP; the median OPP when accessing outpatient care
was $12.57 USD, $62.84 USD for inpatient care and
$18.85 USD for pharmaceuticals [9].
In Ukraine where, in 2009, 16.1% of the population did
not earn a living wage [12], and 14.4% of the population live
below the national poverty line, it is likely that the effect of
OPP for IHD on patient households is great [12,15]. An earl-
ier analysis of the 1996 Income Expenditure Survey found
that approximately 3.9% of households in Ukraine engage in
catastrophic health spending for health care generally [8];
however, this study did not address alternative mechanisms
used by households to finance OPP, such as borrowing and
sale of assets, which are common methods of coping with
OPP in other countries [16-22]. Failure to consider such
coping mechanisms can lead to an overestimate of the effect
of OPP on household consumption in the short-term
(because it ignores the increase in income from alternative
sources), but an underestimate of the longer term
impoverishing impact from indebtedness or the loss of
returns on assets and savings [20,22].
We set out to estimate the impact of OPP for IHD care
on households of patients with angina (one form of IHD)
in Ukraine using data from the World Health Survey 2003
(WHS). In order to account for other household charac-
teristics that may influence household health care spend-
ing we employed the novel ‘Coarsened Exact Matching’
approach [28].
Methods
Data
WHS data with no individual participant identifiers are
publicly available (http://www.who.int/healthinfo/survey/
en/index.html). The WHS sampling procedure is de-
scribed in detail elsewhere [23]. In brief, all Ukrainian
men and women ≥18 years of age in every geographic
region of Ukraine, who were not out of the country dur-
ing the survey period (July/August 2003), were eligible
for sampling. The WHS consisted of an individual ques-
tionnaire and a household questionnaire. Our analysis
included only those who answered both, resulting in a
final sample size of n = 2860. Only one respondent was
selected from each household using Kish tables (a
method used for random selection). Women were over-
sampled (approx. 65%) compared with men (approx.
35%). Sampling weights were included in the WHS data
and were used in this analysis. All WHS participants
provided informed consent prior to study participation.
Angina definition
Because the WHS did not ask specifically about IHD
history (only non-specific “heart disease” history), we
chose to analyze respondents who reported stable angina
pectoris, or typical exertional chest pain, a common
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sequela of IHD. Past international studies have shown
that angina prevalence is strongly associated with non-
fatal myocardial infarction prevalence and other forms
of IHD [24]. Our angina patient sample included those
respondents who reported the following: history of phys-
ician diagnosis and treatment of angina, and a diagnosis
of ‘definite angina’ based on the Rose questionnaire [24].
Physician diagnosis and treatment of angina were de-
fined by affirmative responses to both of the questions:
“Have you ever been diagnosed with angina or angina
pectoris (a heart disease)?” and “Have you ever been
treated for it?” Definite angina based on the Rose ques-
tionnaire was defined by typical affirmative answers to
all Rose questionnaire questions. The Rose question-
naire, sometimes referred to as the London School of
Hygiene Cardiovascular Questionnaire, was developed as
a “standard, unbiased and validated measure of the
prevalence of angina in general populations” [24]. Details
on the adaptation of the Rose questionnaire to the
Ukraine WHS data can be found in Additional file 1:
Table S1.
Household expenditure and financing sources
Expenditures were reported by respondents in Ukrainian
hryvnia and converted into United States dollars (USD)
using the 2003 exchange rate. Monthly per capita total
household expenditure was determined by each respon-
dent’s self-report of total household spending in the last
four weeks, divided by the reported number of people
living in the household. The specific question used in
the WHS was: “In the last four weeks, how much did
your household spend in total?” Monthly per capita
health care expenditure was determined from each re-
spondent’s self-report of total health care costs in the
last four weeks, less any insurance reimbursements, di-
vided by the household size. The specific question used
in this analysis was: “In the last four weeks, how much
did your household spend on health care costs, less any
insurance reimbursements?”. Monthly household expend-
iture on medicines was determined using the respondent’s
self-reported household spending on medicines in the last
four weeks (“In the last four weeks how much did your
household spend on medication or drugs?”). For all three
of these measures, extreme outliers were managed using
‘top-coding’ i.e. reducing their values to that of the 99th
percentile (a method that has been used previously [25].
We opted not to use the aggregate of self-reported item-
ized health spending (which was also included in the
WHS) because in the WHS generally, the average of this
measure is higher than the average reported total health
spending [26] and, therefore, using the reported total pro-
duces in a more conservative estimate of health spending.
We acknowledge that this may result in a higher estimate
of the share of health spending occupied by spending on
medicines than had we used the aggregate of itemized
health spending. Effective monthly income was deter-
mined by subtracting monthly subsistence spending
(defined as the average reported food spending in the last
four weeks of those households in the 45th–55th
percentile of food spending, accounting for household size
(approximately $21.87 USD per person in the household,))
from each household’s self-reported total monthly house-
hold expenditure [8]. This approach was used rather than
subtracting each household’s reported food spending from
their reported total spending because there is evidence
that in poorer households, food expenditure occupies a
larger share of total expenditure [27]; therefore, it is pref-
erable to estimate subsistence expenditure based on the
average food spending of households in the 45–55 per-
centile of food spending. This method was used in a previ-
ous multi-country study of catastrophic health spending
[8]. Households were classified as engaging in catastrophic
spending if monthly health care costs exceeded 40% of ef-
fective income. Financing sources used by households in
the last year to cover health care costs were determined
by the respondents’ response to the question: “In the last
12 months, which of the following financial sources did
your household use to pay for any health expenditures?”.
Coarsened exact matching
A crude comparison of mean household expenditure
and the likelihood of engaging in catastrophic spending
between households with and without an angina patient
would ignore the fact that there may be other character-
istics of angina households that are driving health care
expenditure, such as the number of people or the pro-
portion of elderly living in the household. In order to ac-
count for this, we employed the novel ‘coarsened exact
matching’ method (CEM) [28]. The CEM method has
been described in detail elsewhere [28,29]. Briefly, CEM
attempts to control for the potential confounding influ-
ence of ‘pre-treatment’ covariates on the outcome of
interest, by matching ‘treatment’ cases with ‘non-treat-
ment’ cases that are approximately similar to them with
regard to those covariates. CEM has an advantage over
other methods of matching observational data such as
propensity-score matching (PSM) and exact matching
(EM) in that it doesn’t require that the matched observa-
tions are balanced in terms of pre-treatment covariates
as does PSM, nor does it require matched observations
to be precisely similar in terms of these covariates as in
EM [28,30]. Instead, CEM ‘coarsens’ the pre-treatment
covariates into categories, based on their distribution or
on natural or intuitive divisions [28,30]. In our case,
‘treatment’ cases are angina households and ‘non-treat-
ment’ controls are non-angina households. We used
CEM to account for the potential confounding influence
of the following pre-treatment household characteristics
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on household expenditure: i) household size ii) level of
education attained by the head of the household (to ac-
count for the socio-economic status of the household)
iii) proportion of females in the household (to account
for the generally higher health expenditure associated
with older men) iv) proportion of people over the age of
60 in the household v) proportion of women over the
age of 60 in the household (to account for the longer life
expectancy and therefore possibly higher health care
costs of women in Ukraine) vi) proportion of children
under the age of five in the household and vii) self-
report of arthritis, asthma, depression, schizophrenia/
psychosis or diabetes (to account for co-morbidities that
might affect chronic health care costs). After matching,
we used linear regression to analyse the difference in
mean per capita household net health spending, health
care expenditure and expenditure on medicines associ-
ated with angina households and logistic regression to
analyse the odds of catastrophic spending and of using
various financing mechanisms among angina house-
holds, compared with non-angina households.
Results
Angina prevalence
More than 90% of the Ukraine WHS sample responded
to the angina-related survey questions. Using our defin-
ition of angina, we found an estimated prevalence of
5.5% among men and 8.0% among women (age ≥18 years
old; N = 203). Prevalence of angina by gender and age
group are shown in Table 1. Angina prevalence was
highest in the 70+ age group for both men and women
(15.8% for both).
Household expenditure and financing mechanisms
Table 2 summarizes household expenditure among an-
gina households (for those that responded to the given
questions), as well as the proportion of angina house-
holds engaged in catastrophic health spending. Over
91% of the sample responded to the question about total
household health expenditure. Of those reporting requir-
ing health care in the last 30 days 85% responded to the
question about total household health expenditure in the
last four weeks and of those reporting being prescribed
medicines, 79% responded to the question about ex-
penditure on medicines specifically.
Expenditure on health generally occupied approxi-
mately 32% of effective income, while spending on medi-
cines specifically occupied approximately 27%. Almost
half of angina households were classified as engaging in
catastrophic health spending (44.2%). Table 2 presents
these figures for non-angina households as well (before
matching).
Using the CEM approach we were able to match 139
angina households to non-angina households; the fol-
lowing analyses include only those that were matched
and that responded to the relevant questions. Absolute
differences in mean monthly per capita spending on
health, and on medicines specifically, between angina
households and non-angina households are presented in
Figure 1. After matching, angina households spent an
average of $5.24 (p = 0.001) more on health and $3.90
(p < =0.001) more on medicines compared with non-
angina households (Figure 1). Per capita monthly non-
medical spending did not differ significantly between
the two groups (B = −$3.63, p = 0.295).
Odds ratios (OR) in Table 3 represent the odds of cata-
strophic spending, as well as the odds of financing OPP
from each listed source, among angina households com-
pared with non-angina households. After matching, an-
gina households had 1.36 times the odds of catastrophic
health spending of non-angina households, though this re-
sult was not statistically significant. The odds of financing
OPP using all listed mechanisms were all higher among
angina patients, but only statistically significantly so for
‘sale of assets’ (OR = 6.23) (Table 3). Angina patients were
almost four times more likely to miss work due to ill
health than non-angina respondents.
Discussion
Using a conservative case definition, we found an angina
prevalence of 7.1% in Ukrainian adults aged ≥18 years
from a population-based sample, which is at the higher
end of the angina prevalence range observed in surveys
Table 1 Number and proportion of angina patients by
age and gender, WHS-Ukraine 2003
Age(years) Males (n = 1003*) Females (n = 1847*) Total (n = 2860)
18-39 2 (0.5%) 6 (0.9%) 8 (0.8%)
40-69 35 (7.2%) 99 (10.8%) 134 (9.6%)
70+ 18 (15.8%) 43 (15.8%) 61 (15.4%)
Total 55 (5.5%) 148 (8.0%) 203 (7.1%)
* Male and Female columns do not add up to total due to missing data on
gender for 10 observations.
Table 2 Expenditure and catastrophic spending among
angina and non-angina households in Ukraine, WHS
2003, in 2003 United States Dollars (USD), crude,
unmatched analysis
Angina Non-angina
Per capita monthly household
expenditure (USD)
Mean (S.E.)
All health 9.26 (2.75) 6.25 (0.43)
Medicines only 7.99 (2.37) 4.92 (0.66)
Effective income 29.09 (4.93) 26.76 (1.09)
Proportion (%)
Catastrophic health spending 44.2 35.1
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from around the world [31]. High angina prevalence fits
with IHD mortality rates in Ukraine and the rest of East-
ern Europe, which are among the highest globally [32].
Our estimate of angina prevalence from the WHS
Ukraine is similar to previous estimates for Ukraine
(7.3%) [33], Russia (6.5%) [31] and Georgia (9.4%) [34]
for the same age range, and the female-to-male ratio
(approx. 45% higher) is consistent with the reported
average 20% higher prevalence of angina in women [31].
The proportion of total household effective income
dedicated to OPP for health care in angina patient
households in the Ukraine WHS is much higher than
the national average reported by the State Statistics
Committee in 2002 (approximately 3.2%) [35], and the
largest share of this is spent on medicines. This finding
should be interpreted with caution, as it has been noted
that the WHS generally produces higher estimates of
health expenditure than other surveys [26]. This may
occur because 1) the intensive health focus of the WHS
may cause respondents to include health spending that
occurred prior to the recall period, 2) the recall period
used in the WHS (four weeks) differs from that used in
other expenditure surveys, or 3) the WHS was conducted
later than other surveys (2002–2003) and health spending
may have actually increased in the WHS countries over
that period of time [26]. The WHS 2003 Ukraine Report
itself estimates that approximately 20% of the sample
population experienced catastrophic health spending [36].
This is lower than our estimate of 35% in the non-angina
sample; however, although in both cases catastrophic
health spending was defined as health expenditure exceed-
ing 40% of effective income, where we defined subsistence
spending (used to calculate effective income) as the
average expenditure on food of those households in the
45th–55th percentile of food expenditure (approximate
$59 USD), as done in previous research on the subject
[8,27,37], the WHS Ukraine Report defines subsistence
spending as the poverty line (approximately $50 USD). A
lower estimate of subsistence spending results in a higher
estimate of effective income which in turn reduces the es-
timated proportion of households whose health expend-
iture will reach the catastrophic threshold. This highlights
the sensitivity of estimates of catastrophic spending to dif-
ferences in definition of subsistence and effective income.
Our estimates of catastrophic health expenditure are
also higher than those from previous research in Georgia
(11.7%) [37], another fSU country, which used the same
method of calculating subsistence spending. This may be
partly due to the fact that a higher proportion of Geor-
gians do not seek care when they are ill (61%) compared
to Ukrainians (52%) [9], or to the fact that the question
in the Ukraine WHS that we used to measure health ex-
penditure (i.e. ‘total self-reported household health ex-
penditure) may have captured health expenditures which
might not be included in the Georgian study (such as
health care products and alternative healers). Moreover,
the data used in the Georgian study is from 2009 (the
WHS 2003 Georgia Report estimated catastrophic
spending at about 26% [38]), and it is possible that newer
data from Ukraine would also reflect a reduction in OPP
for health care. However, research shows that prices for
drugs in Ukraine have increased due to the 2008 economic
crisis [39] and, according to data from 2010, 70% of Ukrai-
nians diagnosed with hypertension were not taking
recommended drug treatment [40].
Despite the difference between our estimate and previ-
ous estimates from the region, the levels of OPP for
health care observed in angina households, and in par-
ticular the OPP for medicines, are cause for concern and
should serve as impetus for further research on the fi-
nancial burden faced by angina patients in other
formerly Soviet countries where IHD rates are high and
OPP are common [9]. Our estimates relate only to
chronic, stable angina and not acute hospitalizations for
myocardial infarction or ischemic heart failure. As these
other IHD conditions are likely experienced by many of
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Figure 1 Mean monthly per capita OPP for all health care and
medicines only, angina (n=139) and non-angina (n=1106)
matched households, WHS-Ukraine 2003.
Table 3 Likelihood of engaging in catastrophic spending,
means of financing OPP and missing work among angina
households compared to non-angina households after
matching, WHS-Ukraine 2003
OR S.E. P-value
Catastrophic spending 1.21 0.22 0.285
Means of financing OPP:
Income 1.62 0.44 0.075
Savings 1.02 0.40 0.959
Sale of assets 6.23 3.49 0.001
Borrowing from friends or family 1.42 0.33 0.130
Borrowing from others 1.11 0.41 0.777
Missing work due to ill health* 3.71 2.34 0.038
*This outcome was assessed using the individual level survey, comparing
angina respondents to non-angina respondents.
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the angina patients in our sample, our estimates may
only represent the ‘tip of the iceberg’ in terms of the
economic consequences of IHD in Ukraine. A recent
study conducted in four other low- and middle-income
countries (LMIC) reported high rates of catastrophic
spending among households of patients hospitalized for
an acute IHD event [4]. Although regulated by the
Ukrainian government, prices for pharmaceuticals have
increased in the country due to inflation and lack of
control over prescribing practices – 14% of the 28% in-
crease in pharmaceutical prices observed in the country
between 2006 and 2008 was related to doctors prescrib-
ing more expensive medicines instead of cheaper ones at
various stages of treatment [12].
Our analysis of matched data indicated that house-
holds of angina patients may experience higher OPP
costs for health care relative to non-angina households.
The higher OPP observed for medicines specifically is
not surprising, given that treating angina often requires
a long-term (sometimes life-long) daily medication regi-
men. The OPP costs of medications that treat angina, as
well as other chronic cardiovascular conditions such as
hypertension or heart failure, may provide one possible
explanation for the irregular treatment observed in
Ukraine (73.5% not taking prescribed daily medication)
[40]. In fact, in the Ukraine WHS data, of those angina
patients who reported that the reason for their latest
visit to a doctor was ‘heart disease’, approximately 62%
did not obtain all medicines prescribed to them because
they ‘could not afford’ them (author’s calculations). This
is particularly worrisome given the importance of adher-
ence to a standard daily drug regimen as a means of re-
ducing the likelihood of acute coronary event [41].
Although almost half of angina households were de-
fined as engaging in catastrophic spending, after adjust-
ment for matching their odds of being so were not
significantly higher, nor was their non-medical con-
sumption significantly lower than non-angina house-
holds. This suggests the catastrophic spending measure
may over-estimate the short-term impact of high OPP
on household consumption. One reason for this obser-
vation may be that angina households are partly finan-
cing their consumption by borrowing or selling assets,
thus ‘protecting’ their consumption from the potentially
catastrophic effects of OPP. Indeed, the likelihood of
selling assets to finance OPP was significantly higher
among angina households in the Ukraine WHS.
Engaging in these types of coping mechanisms has been
shown to disguise the longer-term impoverishing effects
of OPP [20], but the extent of this impoverishment may
depend on the character and interest rates imposed by
the lender [22,42], as well as whether any assets sold
were essential to current consumption or surplus to re-
quirements [17]. Some previous qualitative work
suggests that although such coping mechanisms solve
immediate cash flow problems, over the long-term
households may be forced to spend less on education
[43], reduce food or treatment quality or return to work
before fully recovered [44] in order to meet financial ob-
ligations. Further qualitative or longitudinal research is
needed in order to understand the consequences of
these coping mechanisms in the Ukrainian context.
The impoverishing effects of angina on households in
Ukraine might also be underestimated here because we
are not able to measure the indirect effects of ill health
on household finances. In particular, we found that an-
gina patients were almost four times as likely to miss
work due to ill health as matched respondents without
angina; lost wages among these patients, especially if
they are the primary wage-earner in the home, may have
significant long-term effects on household finances that
cannot be measured in this survey. In the case of farm-
ing households, the lost productivity of the ill household
member may be difficult to substitute, especially in
poorer or smaller households [18].
Limitations
Use of the Rose Questionnaire to diagnose angina may
lead to a high rate of false positive angina diagnoses
among women [45]. This is of particular concern in the
present study, in which approximately 73% of angina pa-
tients were female. However, by restricting our angina
definition to those who also self-reported a physician
diagnosis and treatment of angina—a definition that cor-
relates well with prevalence of acute myocardial infarc-
tion survivors and IHD mortality [24] —we made every
effort to account for this potential limitation.
This analysis relies on self-reported data on household
spending, which is subject to measurement error [46,47].
Respondents may provide answers that they believe are
socially acceptable and when asked to provide frequen-
cies or amounts, they may rely on best estimates rather
than recalling and counting [48]. The results of a test-
retest study of the WHS specifically found that respon-
dents in this survey tended to under-report total house-
hold expenditure, and over-report out-of-pocket health
expenditure [26]. This pattern, in addition to the reasons
for high estimates of health spending in the WHS
discussed above, may explain the discrepancy between
the WHS estimates of monthly household out-of-pocket
spending on health and those reported by the State Sta-
tistics Committee of Ukraine. Nonetheless, regarding
our comparative analyses, there is no reason to expect
that within the WHS, self-report should be less accurate
in angina compared with non-angina patients.
Lastly, this analysis relies on WHS data from 2003 and
more recent data would provide a more accurate esti-
mate of the burden of OPP faced by angina patients in
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Ukraine. However, WHO indicators from 2008 show
that private OPP continue to occupy a large percentage
of total health expenditure in the country [14], and
prices for drugs in Ukraine have increased due to the
2008 economic crisis [39], suggesting that significant im-
provements in OPP for chronic health care since 2003
are unlikely.
Conclusion
As the population of Ukraine and other fSU countries
continues to age, and smoking rates among young adults
remains high, the prevalence of NCDs is likely to in-
crease in the future. The cost of managing chronic dis-
ease currently places an burden on households of
patients. Our results suggest that OPP for health care,
especially for medicines, are higher in angina households
and that these expenditures are often financed by bor-
rowing or the sale of assets. The potentially detrimental
effect of such coping mechanisms on households’ liveli-
hoods and the national economy in Ukraine, as well as
in other fSU countries where OPP are high, requires fur-
ther research. Along with increased funding of prevent-
ive public health programs, the burden of health care
costs due to NCDs should be addressed by financing
mechanisms which improve access to outpatient pre-
scription pharmaceuticals as well as stricter regulation
and oversight of prescribing and dispensing practices.
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